کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6262953 1613817 2015 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Research ReportTopiramate attenuates early brain injury following subarachnoid haemorrhage in rats via duplex protection against inflammation and neuronal cell death
ترجمه فارسی عنوان
گزارش تحقیقاتی تپیآمینات آسیب زودرس مغز پس از خونریزی سوباراونوئید در موش های صحرایی را از طریق محافظت دوطرفه در مقابل التهاب و مرگ سلول های عصبی کاهش می دهد
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب (عمومی)
چکیده انگلیسی

●We observes topiramate ameliorate early brain injury after subarachnoid haemorrhage.●The mechanism relies on protections of neuroinflammation and neuronal cell death.●The regulation is mediated by multiple signalling pathways and ion channels.

Early brain injury (EBI) following aneurysmal subarachnoid haemorrhage (SAH) insults contributes to the poor prognosis and high mortality observed in SAH patients. Topiramate (TPM) is a novel, broad-spectrum, antiepileptic drug with a reported protective effect against several brain injuries. The current study aimed to investigate the potential of TPM for neuroprotection against EBI after SAH and the possible dose-dependency of this effect. An endovascular perforation SAH model was established in rats, and TPM was administered by intraperitoneal injection after surgery at three different doses (20 mg/kg, 40 mg/kg, and 80 mg/kg). The animals' neurological scores and brain water content were evaluated, and ELISA, Western blotting and immunostaining assays were conducted to assess the effect of TPM. The results revealed that TPM lowers the elevated levels of myeloperoxidase and proinflammatory mediators observed after SAH in a dose-related fashion, and the nuclear factor-kappa B (NF-κB) signalling pathway is the target of neuroinflammation regulation. In addition, TPM ameliorated SAH-induced cortical neuronal apoptosis by influencing Bax, Bcl-2 and cleaved caspase-3 protein expression, and the effect of TPM was enhanced in a dose-dependent manner. Various dosages of TPM also upregulated the protein expression of the γ-aminobutyric acid (GABA)-ergic signalling molecules, GABAA receptor (GABAAR) α1, GABAAR γ2, and K+-Cl− co-transporter 2 (KCC2) together and downregulated Na+-K+-Cl− co-transporter 1 (NKCC1) expression. Thus, TPM may be an effective neuroprotectant in EBI after SAH by regulating neuroinflammation and neuronal cell death.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Brain Research - Volume 1622, 5 October 2015, Pages 174-185
نویسندگان
, , , , , , ,